Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Clinical Trial of Adaptive Treatment for Early Smoking Cessation Relapse
Sponsor: Medical University of South Carolina
Summary
This is a research study to find out if treatment decision making can be improved for smokers who find it difficult to quit with medications. Everyone who participates in this study will receive free product, either nicotine replacement therapies (patches and lozenges), varenicline, or a harm reduction product (e-cigarette) for a full 12 weeks. Most participants will receive some combination of these treatments, depending on individual response to each. All visits and study assessments will be entirely remote. All treatments will be provided free of charge for the first 12 weeks. After that, the study team will contact the participants 6 months after the first study phone call to complete another survey. The study lasts six months and will involve 8 surveys.
Key Details
Gender
All
Age Range
21 Years - Any
Study Type
INTERVENTIONAL
Enrollment
544
Start Date
2024-03-25
Completion Date
2028-03-31
Last Updated
2026-03-06
Healthy Volunteers
Yes
Interventions
Switching to a different medication
Participants will receive four weeks of the other FDA approved option, either varenicline or combination NRT, with instructions to try to quit again at week 4.
Continued use of the same medication
Participants will receive four additional weeks of the same medication (varenicline or NRT) with instructions to try to quit again at week 4.
Switching to a harm reduction tobacco product
Participants will receive four weeks of e-cigarette products with instructions to switch completely at Week 8
Locations (1)
Medical University of South Carolina
Charleston, South Carolina, United States